trofosfamide has been researched along with rofecoxib in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elmlinger, MW; Plikat, K; Reichle, A; Schölmerich, J | 1 |
| Andreesen, R; Bataille, F; Berand, A; Bross, K; Hafner, C; Jauch, KW; Landthaler, M; Reichle, A; Vogt, T | 1 |
| Andreesen, R; Bataille, F; Berand, A; Bross, K; Krause, SW; Reichle, A; Vogt, T; Wild, P | 1 |
| Coras, B; Hafner, C; Hohenleutner, U; Landthaler, M; Reichle, A; Szeimies, RM; Vogt, T | 1 |
| Andreesen, R; Bachthaler, M; Bretschneider, T; Bross, K; Freund, S; Kunz-Schughart, L; Reichle, A; Vogt, T | 1 |
| Egerer, G; Ho, AD; Kasper, B | 1 |
| Andreesen, R; Berand, A; Bröcker, EB; Coras, B; Landthaler, M; Neuber, K; Reichle, A; Schultz, E; Terheyden, P; Trefzer, U; Vogt, T | 1 |
3 trial(s) available for trofosfamide and rofecoxib
| Article | Year |
|---|---|
Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors.
Topics: Administration, Oral; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Female; Hemangioendothelioma; Hemangiosarcoma; Humans; Lactones; Male; Middle Aged; Pioglitazone; Sulfones; Thiazolidinediones; Treatment Outcome | 2003 |
Anti-inflammatory and angiostatic therapy in chemorefractory multisystem Langerhans' cell histiocytosis of adults.
Topics: Adult; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Resistance, Multiple; Histiocytic Sarcoma; Humans; Lactones; Male; Pioglitazone; Sulfones; Thiazolidinediones | 2005 |
Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Cyclophosphamide; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Lactones; Male; Melanoma; Middle Aged; Pioglitazone; Salvage Therapy; Sulfones; Thiazolidinediones | 2007 |
4 other study(ies) available for trofosfamide and rofecoxib
| Article | Year |
|---|---|
[Hypoglycemia associated with the production of insulin-like growth factor (IGF)-II by a hemangiopericytoma].
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Cyclophosphamide; Female; Hemangiopericytoma; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Lactones; Liver Neoplasms; Pioglitazone; Prednisolone; Recurrence; Sulfones; Thiazoles; Thiazolidinediones; Time Factors | 2003 |
Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C-Reactive Protein; Cyclophosphamide; Female; Humans; Hypoglycemic Agents; Lactones; Male; Melanoma; Middle Aged; Pioglitazone; Sarcoma; Sulfones; Thiazolidinediones; Treatment Outcome | 2004 |
Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma.
Topics: Adult; Angiogenesis Inhibitors; Cyclophosphamide; Drug Therapy, Combination; Endemic Diseases; Humans; Lactones; Male; Mozambique; Pioglitazone; Sarcoma, Kaposi; Skin Neoplasms; Sulfones; Thiazolidinediones; Treatment Outcome | 2004 |
A new therapeutic approach in patients with advanced sarcoma.
Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Female; Humans; Lactones; Male; Middle Aged; Neovascularization, Pathologic; Palliative Care; Pilot Projects; Pioglitazone; Sarcoma; Soft Tissue Neoplasms; Sulfones; Thiazolidinediones; Treatment Outcome | 2005 |